MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation…
Incident arrhythmias in relation to ventilatory parameters and pulmonary disease: evidence from two prospective cohort studies | BMC Medicine
Study population The study included subjects from two cohorts, the ARIC (Atherosclerosis Risk in Communities) and the CHS…